Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orasure Technologies (DE:EP3)
FRANKFURT:EP3
RESEARCH TOOLSreports
Orasure Technologies (EP3) Stock Price & Analysis
0 Followers
EP3 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€3.92 - €7.50
Previous Close€5.1
Volume0.00
Average Volume (3M)425.00
Market Cap
€376.11M
Enterprise Value€117.69M
Total Cash (Recent Filing)$290.41M
Total Debt (Recent Filing)$13.50M
Price to Earnings (P/E)N/A
Beta0.51
Next Earnings
May 08, 2024EPS Estimate
€0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding73,796,268
10 Day Avg. Volume10
30 Day Avg. Volume425
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.03
Price to Sales (P/S)0.90
Price to Cash Flow (P/CF)2.40
P/FCF Ratio2.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.29
Enterprise Value/Gross Profit0.69
Enterprise Value/Ebitda1.52
Forecast
1Y Price Target
€6.52Price Target Upside27.83% Upside
Rating ConsensusHold
Number of Analyst Covering1
Orasure Technologies News
PremiumCompany Announcements
Orasure Technologies Executives Share Annual Update
PremiumPre-Earnings
Orasure (OSUR) Q4 Earnings Cheat Sheet
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
1.44% Other Institutional Investors
98.56% Public Companies and
Individual Investors
EP3 FAQ
What was Orasure Technologies’s price range in the past 12 months?
Orasure Technologies lowest stock price was €3.92 and its highest was €7.50 in the past 12 months.
What is Orasure Technologies’s market cap?
Currently, no data Available
When is Orasure Technologies’s upcoming earnings report date?
Orasure Technologies’s upcoming earnings report date is May 08, 2024 which is in 3 days.
How were Orasure Technologies’s earnings last quarter?
Orasure Technologies released its earnings results on Feb 27, 2024. The company reported €0.252 earnings per share for the quarter, beating the consensus estimate of €0.095 by €0.157.
Is Orasure Technologies overvalued?
According to Wall Street analysts Orasure Technologies’s price is currently Undervalued.
Does Orasure Technologies pay dividends?
Orasure Technologies does not currently pay dividends.
What is Orasure Technologies’s EPS estimate?
Orasure Technologies’s EPS estimate is €0.06.
How many shares outstanding does Orasure Technologies have?
Currently, no data Available
What happened to Orasure Technologies’s price movement after its last earnings report?
Orasure Technologies reported an EPS of €0.252 in its last earnings report, beating expectations of €0.095. Following the earnings report the stock price went up 4.687%.
Which hedge fund is a major shareholder of Orasure Technologies?
Among the largest hedge funds holding Orasure Technologies’s share is PRIMECAP Management Co. It holds Orasure Technologies’s shares valued at 6M.
---
Orasure Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€6.52 (27.83% Upside)
€6.52 (27.83% Upside)
Blogger Sentiment
Bullish
DE:EP3 Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.77%
12-Months-Change
Fundamentals
Return on Equity
13.51%
Trailing 12-Months
Asset Growth
8.58%
Trailing 12-Months
Company Description
Orasure Technologies
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The DNAG segment manufactures and sells specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.
---
EP3 Earnings Call
Q4 2024
0:00 / 0:00
---
EP3 Stock 12 Months Forecast
Average Price Target
€6.52
▲(27.83% Upside)
Technical Analysis
Best Analysts Covering EP3
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
-4.29%
reiterated a buy rating 5 months ago
Copying Patrick B Donnelly's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -4.29% per trade.
---